Indivior Pharmaceuticals, Inc. Common Stock (INDV) is a publicly traded Healthcare sector company. As of July 5, 2026, INDV trades at $39.80 with a market cap of $4.70B and a P/E ratio of 23.69. INDV moved -1.13% today. Year to date, INDV is +11.39%; over the trailing twelve months it is +158.44%. Its 52-week range spans $7.62 to $42.81. Analyst consensus is strong buy with an average price target of $51.00. Rallies surfaces INDV's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
4 analysts cover INDV: 0 strong buy, 4 buy, 0 hold, 0 sell, and 0 strong sell. The consensus rating is strong buy. The average price target is $51.00.
| Metric | Value |
|---|---|
| Price | $39.80 |
| Market Cap | $4.70B |
| P/E Ratio | 23.69 |
| EPS | $1.68 |
| Dividend Yield | 0.00% |
| 52-Week High | $42.81 |
| 52-Week Low | $7.62 |
| Volume | 0 |
| Avg Volume | 0 |
| Revenue (TTM) | $1.24B |
| Net Income | $210.00M |
| Gross Margin | 80.23% |
4 analysts cover INDV: 0 strong buy, 4 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $51.00.